Recently, we discovered a dependency of cancer persistence on type I PRMTs in lung cancer cells with high STAT1 signaling levels (21), which can arise from a number of factors, including intrinsic cancer cell signals, microenvironmental cytokines, and/or treatment-induced adaptation (21–28). This evidence concerns the gene STAT1 and lung carcinoma.